Skip to content
Open access

Differentially expressed genes in CD34+ cells in Ph-negative myeloproliferative neoplasms: bioinformatics meta-analysis of three independent studies

Sep 2026 · Oncohematology · Vol 21, pp. 113-126 · 0 citations · 44 references

TL;DR

The functional annotation confirms the pathogenetic mechanisms of the disease: impaired DNA repair, apoptosis, proliferative and functional activation, and the development of inflammatory processes in the bone marrow, and suggests a single pathogenetic mechanism for the evolution of MPNs.

Abstract

Accumulating evidence suggests that the molecular pathobiology of Ph-negative myeloproliferative neoplasms (MPNs) is significantly more complex than expected, with associated somatic mutations failing to fully explain the underlying causes and maintaining a high degree of uncertainty regarding individual disease prognosis. Given the involvement of epigenetic mechanisms of carcinogenesis in altered gene expression, attempts have been made to identify specific transcriptome alterations in hematopoietic cells in MPNs. However, these results often inconsistently reflect the use of different analytical technologies, statistical approaches, and the small number of patients included. Aim – to perform a bioinformatics meta-analysis of available databases of primary results from microarray studies of CD34+ cell RNA profiling in patients with MPNs. The NCBI GEO catalog was used to search for raw data. After searching for the keyword “myeloproliferative neoplasm”, three independent databases were identified that matched the Affymetrix analytical platform and biomaterial type. Processing was performed in the integrated RStudio development environment using the oligo package. Gene expression normalization was performed using the robust multiarray average method. Differential gene expression analysis in CD34+ cells between patient groups was performed using the limma package. To enhance the reliability of the results, a meta-analysis was performed using a combination of Fisher’s and Stauffer’s methods, with the Jackknife procedure used for final filtering. The meta-analysis identified 33 genes common to MPN, as well as 7, 204, and 1806 genes specific to essential thrombocythemia, polycythemia vera, and primary myelofibrosis, respectively, that were differentially expressed. The PIM1 gene expression level significantly varied in the series control → essential thrombocythemia → polycythemia vera → primary myelofibrosis. The functional annotation confirms the pathogenetic mechanisms of the disease: impaired DNA repair, apoptosis, proliferative and functional activation, and the development of inflammatory processes in the bone marrow. It also demonstrates the multilevel nature of the interactions between intracellular signaling pathways and the pleiotropy of regulatory processes in carcinogenesis. Overall, the obtained data are consistent with Dameshek’s biological continuum postulate, which suggests a single pathogenetic mechanism for the evolution of MPNs.

Read PDF

Similar papers

Sep 2026

Integrative omics profiling of CRELD2 in ccRCC: a nexus of genetics, prognosis, and tumor microenvironment

The CRELD2-centered TLS-associated immune-inflammatory conceptual axis is pointed out, linking CRELD2 expression, endothelial/B-cell cellular contexts, B-cell-related immune infiltration, TLS-associated spatial localization, and recurrent TNFA/NFκB pathway enrichment via multi-omics and supporting it as a candidate the...

Shou-Yong Liu, Yu-Lin Zhou, Li Fan et al. · 0 citations
Open access Sep 2026

Genomic Characterization of RTK-RAS Pathway Alterations in Juvenile Myelomonocytic Leukemia Through Whole-Exome Sequencing

Background/Objectives: Juvenile myelomonocytic leukemia (JMML) is a rare and very aggressive pediatric myelodysplastic/myeloproliferative neoplasm with molecular heterogeneity and constitutive activation of the RAS signaling pathway. The aim of this study was to identify the mutational landscape, driver genes, mutation...

Harsh Goel, R. Majhi, J. Meena et al. · 0 citations
Open access Oct 2026

ZC3H15 in human tumors: a pan-cancer exploration of its clinical significance, molecular function, and association with the tumor immune microenvironment

Background Zinc finger CCCH-type protein 15 (ZC3H15) is a ribosome-associated eukaryotic protein involved in many biological processes, including gene expression regulation, translation, and immune modulation. Although ZC3H15 has been implicated in the development of certain tumors, its expression, functional relevance...

Bin Zhou, Jian Huang, Qi-Fei Tao et al. · 0 citations
Open access 2026

The MIR142 gene in lymphomas: a comprehensive analysis of data from cBioPortal for Cancer Genomics and our own findings

Introduction. MicroRNA miR-142 is involved at multiple levels in the pathogenesis of diffuse large B-cell lymphoma (DLBCL): mature chains are oncosuppressive and target a number of pro-oncogenes that are essential for lymphomagenesis. Aim. To perform a comparative analysis of the frequency and spectrum of aberrations (...

E. Voropaeva, O. Seregina, M. Voytko et al. · 0 citations
Clinical trial Open access Oct 2026

PIK3CA Mutations in Advanced or Recurrent Endometrial Cancer: An Exploratory Molecular Profiling From the Phase II MITO END-3 Study

Purpose Immunotherapy with chemotherapy significantly improves progression-free survival in advanced endometrial cancer (EC), especially in microsatellite instability-high (MSI-H) cases. Despite this, for recurrent EC in the postimmunotherapy setting, new treatment options are urgently needed. The PI3K pathway is frequ...

A. Passarelli, G. L. Scaglione, D. Califano et al. · 0 citations
Open access Sep 2026

Integrative multi-omics characterization of KLRB1/CD161 in diffuse large B-cell lymphoma: associations with immune context, subtype biology, and therapeutic response

Background The tumor immune microenvironment (TME) of diffuse large B-cell lymphoma (DLBCL) displays pronounced heterogeneity, and existing immunotherapeutic approaches achieve only suboptimal outcomes for a considerable proportion of affected individuals. CD161—a C-type lectin receptor whose coding gene is KLRB1—has l...

Er-Wei Li, Ying-Ying Tang, Yuanyuan Wanyan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.